SelectQuoteSLQT
SLQT
About: SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
Employees: 4,292
0
Funds holding %
of 7,321 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
238% more call options, than puts
Call options by funds: $6.27M | Put options by funds: $1.85M
200% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 16
100% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 2 (+1) [Q1 2025]
38% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 40
21% more funds holding
Funds holding: 147 [Q4 2024] → 178 (+31) [Q1 2025]
3.88% more ownership
Funds ownership: 37.66% [Q4 2024] → 41.54% (+3.88%) [Q1 2025]
1% less capital invested
Capital invested by funds: $240M [Q4 2024] → $239M (-$1.51M) [Q1 2025]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$2.75
29%
upside
Avg. target
$2.75
29%
upside
High target
$2.75
29%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
Jefferies David Windley | 29%upside $2.75 | Hold Initiated | 21 May 2025 |
Financial journalist opinion
Based on 16 articles about SLQT published over the past 30 days
Neutral
Business Wire
1 day ago
SelectQuote Unveils New Program Designed to Elevate Health Plan Performance by Improving Medication Adherence for Polychronic Medicare Beneficiaries
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) (the “Company”), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced the expanded launch of their innovative concierge-like service designed to specifically improve medication adherence for Medicare beneficiaries managing multiple chronic conditions and complex medication regimens. SelectQuote's SelectRx pharmacy recently trialed a new approach with.
Neutral
GlobeNewsWire
5 days ago
SelectQuote, Inc. Investor News: If You Have Suffered Losses in SelectQuote, Inc. (NYSE: SLQT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public.
Positive
Seeking Alpha
6 days ago
SelectQuote: Be Patient Until Growth Drivers Kick In
SelectQuote is undervalued at current levels, offering a compelling buying opportunity despite recent volatility and a disappointing Q3. Key catalysts include higher Medicare Advantage reimbursement rates, growing recurring revenue from SelectRx, and operational improvements boosting efficiency and margins. The company's valuation is attractive at less than 6x forward adjusted EBITDA, with confirmed growth drivers for both revenue and profitability in FY25 and beyond.
Neutral
GlobeNewsWire
1 week ago
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages SelectQuote, Inc. Investors to Inquire About Securities Class Action Investigation – SLQT
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public.
Neutral
PRNewsWire
1 week ago
Rosen Law Firm Encourages SelectQuote, Inc. Investors to Inquire About Securities Class Action Investigation - SLQT
NEW YORK , July 8, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public. So what: If you purchased SelectQuote securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Neutral
GlobeNewsWire
1 week ago
SelectQuote, Inc. Investor News: If You Have Suffered Losses in SelectQuote, Inc. (NYSE: SLQT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public.
Neutral
PRNewsWire
2 weeks ago
Rosen Law Firm Encourages SelectQuote, Inc. Investors to Inquire About Securities Class Action Investigation - SLQT
NEW YORK , July 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public. So what: If you purchased SelectQuote securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Neutral
GlobeNewsWire
2 weeks ago
SelectQuote, Inc. Investor News: If You Have Suffered Losses in SelectQuote, Inc. (NYSE: SLQT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public. SO WHAT: If you purchased SelectQuote securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Neutral
Business Wire
2 weeks ago
SelectQuote Mourns the Passing of Tom Grant, Vice Chairman of the Board of Directors
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE:SLQT) announced today that William Thomas (Tom) Grant II, Vice Chairman and former President of SelectQuote, passed away on July 1, 2025, following a battle with cancer. Tom was instrumental in formulating and executing SelectQuote's strategy over the past fifteen years as the business evolved from a term life insurance brokerage into a diversified insurance and rapidly-growing healthcare services business. His strategic insights and.
Positive
Zacks Investment Research
2 weeks ago
What Makes SelectQuote (SLQT) a New Buy Stock
SelectQuote (SLQT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Charts implemented using Lightweight Charts™